Healthcare -
Biotechnology - NASDAQ - US
$ 0.0427
-0.928 %
$ 3.22 M
Market Cap
-0.15
P/E
GRTX - COST OF REVENUE
Cost of Revenue GRTX - Galera Therapeutics, Inc.
259 K
LAST VALUE
-42.30%
2 YEAR CAGR
15.32%
5 YEAR CAGR
0.00%
10 YEAR CAGR